Files

Download

Download Full Text (501 KB)

Program

WSU Medical School

Training Level

Medical Student

Institution

Wayne State University

Abstract

Anti-tumor necrosis factor (TNF) agents are used to treat various inflammatory disorders, such as rheumatoid arthritis, irritable bowel disease, and hidradenitis suppurativa (HS). A known side effect of these agents is the development of autoimmunity with the formation of antinuclear antibodies and/or anti-dsDNA antibodies. Although patients sometimes develop these antibodies, they rarely exhibit clinical manifestations. If symptoms do develop, the diagnosis of anti-TNF induced lupus (ATIL) should be considered. We describe a case of adalimumab-induced lupus in a patient with hidradenitis suppurativa.

Publication Date

5-2019

Adalimumab-induced lupus in a patient with hidradenitis suppurativa

Share

COinS